Regenerex Pharma (RGPX) Shares Outstanding (Diluted Average) (2010 - 2014)

Regenerex Pharma (RGPX) has 5 years of Shares Outstanding (Diluted Average) data on file, last reported at $153.0 million in Q4 2014.

• Quarterly Shares Outstanding (Diluted Average) rose 1.77% year-over-year to $153.0 million in Q4 2014, while the trailing twelve-month figure through Nov 2014 was $153.0 million (up 1.77% YoY) and the FY2014 annual result came in at $153.0 million, up 1.77% from the prior year.
• Shares Outstanding (Diluted Average) was little changed at $153.0 million in Q4 2014 per RGPX's latest filing, from $153.1 million in the prior quarter.
• Across five years, Shares Outstanding (Diluted Average) topped out at $153.1 million in Q3 2014 and bottomed at $98.2 million in Q3 2011.
• The 5-year median for Shares Outstanding (Diluted Average) is $149.1 million (2013), against an average of $144.3 million.
• The widest annual swing landed in 2011, when Shares Outstanding (Diluted Average) slumped 30.63%; it then jumped 45.98% in 2012.
• Tracing RGPX's Shares Outstanding (Diluted Average) over 5 years: stood at $141.5 million in 2010, then tumbled by 30.63% to $98.2 million in 2011, then surged by 46.1% to $143.5 million in 2012, then rose by 4.77% to $150.3 million in 2013, then grew by 1.77% to $153.0 million in 2014.
• Per Business Quant, the three latest RGPX Shares Outstanding (Diluted Average) figures stand at $153.0 million (Q4 2014), $153.1 million (Q3 2014), and $151.2 million (Q2 2014).

Peer Comparison